The preferential homing of mesenchymal stromal cells to sites of inflammation

Sullivan, Catherine

doi:10.1002/9781118907474.ch22

The Biology and Therapeutic Application of Mesenchymal Cells 2016

DOI: 10.1002/9781118907474.ch22

|View full text |Cite

The preferential homing of mesenchymal stromal cells to sites of inflammation

Catherine Sullivan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2019

2021

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 243 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Pretreating Mesenchymal Stem Cells with Cancer Conditioned‐Media or Proinflammatory Cytokines Changes the Tumor and Immune Targeting by Nanoghosts Derived from these Cells

Lupu-Haber

Bronshtein

Shalom-Luxenburg

et al. 2019

Adv Healthcare Materials

View full text Add to dashboard Cite

COMMUNICATION (1 of 8)Nanoghosts (NGs) is a proprietary novel form of a targeted delivery platform, which is based on nanovesicles that are technologically reconstructed from the whole cytoplasmic membranes of human bone marrow-derived mesenchymal stem cells (MSCs). Initially developed for tumor-targeted drug Nanoghosts (NGs) are nanovesicles reconstructed from the cytoplasmic membranes of mesenchymal stem cells (MSCs). By retaining MSC membranes, the NGs retain the ability of these cells to home in on multiple tumors, laying the foundations, thereby, for the development of a targeted drug delivery platform. The susceptibility of MSCs to functional changes, following their exposure to cytokines or cancer-derived conditioned-media (CM), presents the opportunity to modify the NGs by conditioning their source cells. This opportunity is investigated by comparing the membrane protein composition and the tumor uptake of NGs derived from naïve MSCs (N-NG) against conditioned NGs made from MSCs pre-treated with conditionedmedia (CM-NG) or with a mix of the proinflammatory cytokines TNF-α and IL-1β (Cyto-NG). CM-NGs are found to be more targeted towards immune cells than Cyto-or N-NGs, while Cyto-NGs are the most tumor-targeted ones, with similar immune-targeting capacity as N-NGs but with a higher affinity towards endothelial cells. Proteomic variations were wider in the CM-NGs, with exceptionally higher levels of ICAM-1 compared to N-and Cyto-NGs. From a translational point of view, the data show that the tumor-targeting ability of the NGs, and possibly that of other MSC-derived extracellular vesicles, can be enhanced by simple conditioning of their source cells.

show abstract

Pretreating Mesenchymal Stem Cells with Cancer Conditioned‐Media or Proinflammatory Cytokines Changes the Tumor and Immune Targeting by Nanoghosts Derived from these Cells

Lupu-Haber

Bronshtein

Shalom-Luxenburg

et al. 2019

Adv Healthcare Materials

View full text Add to dashboard Cite

show abstract

New insights into the application of nanoghosts as theranostic tools with an emphasis on cardiovascular diseases

et al. 2021

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

The preferential homing of mesenchymal stromal cells to sites of inflammation

Cited by 2 publications

References 243 publications

Pretreating Mesenchymal Stem Cells with Cancer Conditioned‐Media or Proinflammatory Cytokines Changes the Tumor and Immune Targeting by Nanoghosts Derived from these Cells

Pretreating Mesenchymal Stem Cells with Cancer Conditioned‐Media or Proinflammatory Cytokines Changes the Tumor and Immune Targeting by Nanoghosts Derived from these Cells

New insights into the application of nanoghosts as theranostic tools with an emphasis on cardiovascular diseases

Contact Info

Product

Resources

About